Abstract
Several recent studies have focused on the association between the promoter polymorphisms 786T/C of the endothelial nitric oxide synthase (eNOS) gene and susceptibility to atrial fibrillation (AF); however, results have been conflicting. We searched Medline, Embase, and the ISI Web of Science through July 1, 2011. Five studies with 1,130 AF cases and 2,340 controls were selected. Odds ratios (ORs) and 95 % confidence intervals (CIs) were calculated based on fixed- and random-effects models. There was no overall association between eNOS 786T/C and AF risk. In subgroup analysis, stratified by ethnicity, we observed a positive association between the eNOS 786T/C polymorphism and AF risk among Caucasians but not among mixed populations. When stratifying by control source, the overall ORs for population- and hospital-based studies were 1.07 (95 % CI, 0.50–2.30) and 0.79 (95 % CI, 0.65–0.97) for CC vs. 22T carriers, respectively. In the studies with a sample size greater than 200, the eNOS 786T/C polymorphism decreased AF risk (OR [95 % CI]: 0.79 [0.64–0.97] for CC vs. T carriers). This meta-analysis suggests that the 786T/C polymorphism of the eNOS gene is protective against AF risk among Caucasians. Additional large studies based on diverse populations are required to validate this conclusion.
Similar content being viewed by others
References
Holmqvist, F., Olesen, M. S., Tveit, A., Enger, S., Tapanainen, J., Jurkko, R., et al. (2011). Abnormal atrial activation in young patients with lone atrial fibrillation. Europace, 13, 188–192.
Klemenz, B. (2011). Screening for atrial fibrillation. British Journal of General Practice, 61, 295.
Lupo, P., & Cappato, R. (2010). Atrial fibrillation ablation in the real world. G Ital Cardiol (Rome), 11, 17S–20S.
Murray, S., Lazure, P., Pullen, C., Maltais, P., & Dorian, P. (2011). Atrial fibrillation care: challenges in clinical practice and educational needs assessment. Canadian Journal of Cardiology, 27, 98–104.
Patterson, S., Wolfe, D. A., & Bower, B. (2010). Atrial fibrillation. A concise update on treatment. Advance for NPs and PAs, 1(20–2), 4.
Kopec, J. A., & Esdaile, J. M. (1990). Bias in case–control studies. A review. Journal of Epidemiology Community Health, 44, 179–186.
Marangoni, K., Araujo, T. G., Neves, A. F., & Goulart, L. R. (2008). The -786T>C promoter polymorphism of the NOS3 gene is associated with prostate cancer progression. BMC Cancer, 8, 273.
Brenol, C. V., Chies, J. A., Brenol, J. C., Monticielo, O. A., Franciscatto, P., Birriel, F., et al. (2009). Endothelial nitric oxide synthase T-786 C polymorphism in rheumatoid arthritis: association with extraarticular manifestations. Clinical Rheumatology, 28, 201–205.
Nagassaki, S., Herculano, R. D., Graeff, C. F., & Tanus-Santos, J. E. (2009). eNOS T-786 C polymorphism affects atorvastatin-induced changes in erythrocyte membrane fluidity. European Journal of Clinical Pharmacology, 65, 385–392.
Jabrocka-Hybel, A., Kolasinska-Kloch, W., Malczewska-Malec, M., Kiec-Wilk, B., Kwasniak, M., Kloch, M., et al. (2007). Gene polymorphisms predisposing to cardiac hypertrophy in patients with cardiac syndrome X. Folia Medica Cracoviensia, 48, 57–69.
Xu, L. X., Yang, W. Y., Zhang, H. Q., Tao, Z. H., & Duan, C. C. (2008). Study on the correlation between CETP TaqIB, KCNE1 S38G and eNOS T-786 C gene polymorphisms for predisposition and non-valvular atrial fibrillation. Zhonghua Liu Xing Bing Xue Za Zhi, 29, 486–492.
van Beynum, I. M., Mooij, C., Kapusta, L., Heil, S., den Heijer, M., & Blom, H. J. (2008). Common 894G>T single nucleotide polymorphism in the gene coding for endothelial nitric oxide synthase (eNOS) and risk of congenital heart defects. Clinical Chemistry and Laboratory Medicine, 46, 1369–1375.
Huttunen, R., Hurme, M., Laine, J., Eklund, C., Vuento, R., Aittoniemi, J., et al. (2009). Endothelial nitric oxide synthase G894T (GLU298ASP) polymorphism is associated with hypotension in patients with E. coli bacteremia but not in bacteremia caused by a gram-positive organism. Shock, 31, 448–453.
Fatini, C., Sticchi, E., Genuardi, M., Sofi, F., Gensini, F., Gori, A. M., et al. (2006). Analysis of minK and eNOS genes as candidate loci for predisposition to non-valvular atrial fibrillation. European Heart Journal, 27, 1712–1718.
Gensini, F., Padeletti, L., Fatini, C., Sticchi, E., Gensini, G. F., & Michelucci, A. (2003). Angiotensin-converting enzyme and endothelial nitric oxide synthase polymorphisms in patients with atrial fibrillation. Pacing and Clinical Electrophysiology, 26, 295–298.
Giusti, B., Gori, A. M., Marcucci, R., Sestini, I., Saracini, C., Sticchi, E., et al. (2007). Role of C677T and A1298C MTHFR, A2756G MTR and −786 C/T eNOS gene polymorphisms in atrial fibrillation susceptibility. PLoS One, 2, e495.
Bedi, M., McNamara, D., London, B., & Schwartzman, D. (2006). Genetic susceptibility to atrial fibrillation in patients with congestive heart failure. Heart Rhythm, 3, 808–812.
Kavvoura F. K., & Ioannidis J. P. (2005). CTLA-4 gene polymorphisms and susceptibility to type 1 diabetes mellitus: a HuGE review and meta-analysis. American Journal of Epidemiol, 162(1), 3–16.
Xi, B., Zeng, T., Liu, L., Liang, Y., Liu, W., Hu, Y., et al. (2011). Association between polymorphisms of the renin-angiotensin system genes and breast cancer risk: a meta-analysis. Breast Cancer Research and Treatment, 130(2), 561–568.
Liu, T., Korantzopoulos, P., Xu, G., Shehata, M., Li, D., Wang, X., et al. (2011). Association between angiotensin-converting enzyme insertion/deletion gene polymorphism and atrial fibrillation: a meta-analysis. Europace, 13, 346–354.
Liu, L., Wang, K., Zhu, Z. M., & Shao, J. H. (2011). Associations between P53 Arg72Pro and development of digestive tract cancers: a meta-analysis. Archives of Medical Research, 42, 60–69.
Author information
Authors and Affiliations
Corresponding author
Additional information
Hongying Chen and Hongxia Chu are equally contributing authors.
Rights and permissions
About this article
Cite this article
Chen, H., Chu, H., Shi, Y. et al. Association Between Endothelial Nitric Oxide Synthase Polymorphisms and Atrial Fibrillation: A Meta-analysis. J. of Cardiovasc. Trans. Res. 5, 528–534 (2012). https://doi.org/10.1007/s12265-012-9375-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12265-012-9375-6